Global Immunoassay Market Strategies & Trends Report 2023-2027: From Clinical to Consumer - Immunoassay's Expanding Footprint in Diagnostics
11 Sep 2023
AcquisitionDiagnostic ReagentsImmunotherapy
DUBLIN, Sept. 11, 2023 /PRNewswire/ -- The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to
ResearchAndMarkets.com's offering.
Preview
Source: PRNewswire
In the ever-evolving landscape of the diagnostic industry, immunoassay is emerging as a steadfast workhorse, finding new relevance driven by the demands of the ongoing pandemic. The need for rapid, easily accessible diagnostics has propelled immunoassay to the forefront, as it adapts and advances in response to shifting market dynamics.
Advancements in genetic knowledge are opening up new avenues for immunoassay technologies, with multiplex capabilities becoming the standard. This transformation extends to rapid diagnostics, point-of-care solutions, biomarker exploration, and the expanding consumer market, while traditional immunoassay methods continue to hold a strong position within the growing realm of clinical diagnostics.
Within the realm of immunoassay instrumentation, multiple factors are fueling growth, including ongoing diagnostic breakthroughs, the retirement of older instruments driven by evolving technologies, wider consumer adoption, and the maturation of immunity-related technology.
However, these opportunities are not without their challenges. Heightened competition is exerting downward pressure on prices, while the threat from PCR-based instruments looms. Lower barriers to entry and potential drawbacks associated with wellness trends also present limitations to growth.
This dynamic landscape is characterized by enduring instruments, industry structures in flux due to declining instrument costs, and meticulous instrument specifications, which play a pivotal role in shaping the field. Innovations like CRISPR diagnostics further contribute to the evolving immunoassay landscape.
With profiles of over 60 companies, spanning both large and small players in this field, this comprehensive report offers invaluable insights into the pitfalls and opportunities that define the immunoassay industry. It equips stakeholders to make informed investment decisions and valuations, providing the latest data to navigate this ever-changing landscape with confidence.
Key Topics Covered:
Industry Overview
Players in a Dynamic Market
Academic Research Lab
Diagnostic Test Developer
Instrumentation Supplier
Chemical/Reagent Supplier
Pathology Supplier
Independent Clinical Laboratory
Public National/regional Laboratory
Hospital Laboratory
Physicians Office Lab (POLS)
Audit Body
Certification Body
The Clinical Laboratory Market Segments
Traditional Market Segmentation
Laboratory Focus and Segmentation
Hospital Testing Share
Economies of Scale
Hospital vs. Central Lab
Physician Office Lab's
Physician's and POCT
Immunoassay - Markets and Discussion
Instruments - Genetics changes the picture
RIA - A Technology Shows its Age
Immunoassay vs. PCR vs. Sequencing - A See Saw Battle
The Smart Shrinking Instrument - Serious Implications
Research Funding and Capital Expense - Instrument Pooling
Multiplex vs. POC - A Tradeoff Analysis
Reagents and Kits - Genetics changes the picture
Bigger Test Menus a Boon for Kit Market
Physician Office Labs - A New Frontier
Rapid and POCT to Threaten Instrument Markets
OTC and DTC - Huge Market Potential
Economies of Scale. Going Away?
Lower Barriers to Entry for Instruments/Analyzers
Miniturization and Technology Drive Acquisition
Immunoassay Recent Developments
Recent Developments - Importance and How to Use This Section
EDP Biotech, New Day Diagnostics to Merge
Sorrento Therapeutics Nabs Contract for Dx Platform
Beckman Coulter Diagnostics DxI 9000 Access Immunoassay Analyzer
Qorvo Eyes Multiplex Immunoassay
BioMerieux Launches New Products
Senzo to Commercialize Infectious Disease Lateral Flow Tests
Nanomix Plans Instrument, Test Launches
Startup GLX Analytix Prepares for Commercialization
Nonagen Gets CE Mark for Bladder Cancer Immunoassay
Saladax Biomedical Using Immunoassay Dx
Prolight Diagnostics to Acquire Psyros Diagnostics
Quidel to Acquire Ortho Clinical Diagnostics
FDA Grants EUA to Xtrava Health
Alamar Biosciences Develops Immuno-Sandwich Platform
FDA grants breakthrough device to multiplex immunoassay
Quidel, Beckman Settle Cardiac Immunoassay Dispute
BGI Americas, Advaite Form SARS-CoV-2 Testing Partnership
BioMerieux Gets CE Mark for Three Dengue Immunoassays
COVID-19 Portfolio to Accelerate At-Home Infectious Disease Testing
Roche Diagnostics Expanding Testing Portfolio in 2021
PerkinElmer Long-Term Outlook
Quidel Updates Outlook for C19 Testing
Dx Companies Look at Multiplex Tests for SARS-CoV-2, Influenza
Becton Dickinson and NAT Diagnostics Acquisition
Market Trends
Factors Driving Growth
Diagnostic Factors
Changing Technologies Spur Early Instrument Retirement
Consumer Channels Open Wider
Immunity Technology Comes of Age
Factors Limiting Growth
Increased Competition Lowers Price
Threat from PCR Based Instruments
Lower Barriers to Entry
Wellness has a downside
Immunoassay Instrumentation
Instrumentation Tenacity
Declining Cost of Instruments Changes Industry Structure
LISTING of INSTRUMENT SPECIFICATIONS
Immunoassay - CRISPR Diagnostics
Market Guides
Immunoassay Market - Strategic Situation Analysis
Guide for Executives, Marketing, Sales and Business Development Staff
Guide for Management Consultants and Investment Advisors
Market Definition
Immunoassay Markets Definition In This Report
Enzyme Based
Immunofluorescence
Chemiluminescence
DNA/NAT
RIA & Other
Reagents/Kits, Analyzers, Software & Services
Auto Immune
Endocrinology
Oncology
Cardiology
Other Specialty
Market Definition
Methodology
Perspective: Healthcare and the IVD Industry
Global Healthcare Spending
Spending on Diagnostics
Important Role of Insurance for Diagnostics
Appendices
United States Medicare System: Laboratory Fees Schedule
The Most Used IVD Assays
The Highest Grossing Assays
Profiles of Key Companies
Applied BioCode
Becton, Dickinson and Company
FUJIFILM Wako Diagnostics
Fujirebio
Immunodiagnostic Systems (IDS)
Immunodiagnostik AG
JR Biomedical
Meso Scale Discovery
Millipore Sigma
Mindray
Molecular Devices
MP Biomedical
Perkin Elmer
Quidel
SD Biosensor
Siemens Healthineers
Tecan
Scope of the Report
Global Market by Application
Endocrinology Applications
Immune Applications
Oncology Applications
Infectious Disease Applications
Cardiology Applications
Other Applications
Immunoassay by Technology
Enzyme
Flourescence
Chemiluminescence
Nucleic Acid
Rapid/POC
Other Technology
Immunoassay by Product
Instrument
Reagents
Services
Immunoassay by User
Hospital
Outpatient Lab
POC/Other
12 Vision of the Future of Immunoassay
For more information about this report visit https://www.researchandmarkets.com/r/srmshg
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.